Its role and its contribution to the pathogenesis of chronic periodontitis, tissue destruction and bone loss has been clearly documented [48]–[50] and administration of anti-TNF-α antibodies resulted in reduced alveolar bone loss [51]–[54]. The gene discussed is TNF; the disease is chronic periodontitis.